Skip to content

Pulmonary Fibrosis and Telomerase Mutation Study

Phenotype of Pulmonary Fibrosis Associated With a Mutation of Telomerase

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01501578
Enrollment
81
Registered
2011-12-29
Start date
2011-12-31
Completion date
2015-12-31
Last updated
2018-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pulmonary Fibrosis

Keywords

Pulmonary fibrosis, Telomerase mutation

Brief summary

This study is an observational and retrospective study of patients with pulmonary fibrosis associated or not with telomerase mutation. The purpose of this study is to describe in detail the cases with telomerase mutation in terms of features on CT scan, respiratory function and evolution, in comparison to control subjects with idiopathic pulmonary fibrosis and no telomerase mutation identified or family history.

Detailed description

Two control subjects will be enrolled for one subject with telomerase mutation. The data are all the results of investigations conducted for the diagnosis of idiopathic pulmonary fibrosis and during routine follow up of patients. The CT scans will reviewed centrally to homogenize the description.

Interventions

None listed

Sponsors

Bichat Hospital
CollaboratorOTHER
Groupe d'Etudes et de Recherche sur les Maladies Orphelines Pulmonaires
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Diffuse interstitial lung disease on CT scan * Telomerase mutation analysis

Exclusion criteria

* Presence of connective tissue disease, or pneumoconiosis or drug induced lung disease

Design outcomes

Primary

MeasureTime frameDescription
Description of imaging patternat baseline onlyDescription of imaging pattern on representative CT scan at diagnosis.

Secondary

MeasureTime frameDescription
Pathology of the lungat baseline onlydescription of pathological pattern
Pulmonary function testsfrom diagnosis to last follow-up, for an average of one yearanalyze the respiratory function

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026